Dual mTOR/PI3K inhibitor NVP‑BEZ235 arrests colorectal cancer cell growth and displays differential inhibition of 4E‑BP1-Reference-Cited by-同舟云学术

Dual mTOR/PI3K inhibitor NVP‑BEZ235 arrests colorectal cancer cell growth and displays differential inhibition of 4E‑BP1

Published:2018-05-22 Issue: Volume: Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Alqurashi Naif¹,Hashimi Saeed¹,Alowaidi Faisal²,Ivanovski Saso³,Wei Ming³

Affiliation:

1. Department of Basic Sciences, Deanship of Preparatory Studies, Imam Abdulrahman Bin Faisal University, Dammam 34212, Kingdom of Saudi Arabia

2. Department of Pathology and Laboratory Medicine, College of Medicine and University Hospitals, King Saud University, Riyadh 11461, Kingdom of Saudi Arabia

3. School of Medical Science and Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland 4333, Australia

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selective PI3Kδ inhibitor TYM-3-98 suppresses AKT/mTOR/SREBP1-mediated lipogenesis and promotes ferroptosis in KRAS-mutant colorectal cancer;Cell Death & Disease;2024-07-03

2. Dual PI3K/mTOR Inhibitor BEZ235 combined with BMS-1166 Promoting Apoptosis in Colorectal Cancer;International Journal of Medical Sciences;2024

3. Small-molecule drugs of colorectal cancer: Current status and future directions;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-01

4. LncRNA SBF2 Antisense RNA 1 Accelerates the Progression of Colon Cancer via PI3K/Akt/mTOR Signaling Pathway by Targeting miR-506-3p/ZEB1 Axis;Journal of Biomedical Nanotechnology;2023-11-01

5. MNK, mTOR or eIF4E-selecting the best anti-tumor target for blocking translation initiation;European Journal of Medicinal Chemistry;2023-11